Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.
about
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsNeurological immune reconstitution inflammatory response: riding the tide of immune recoveryMethods of rapid diagnosis for the etiology of meningitis in adultsExploiting fungal cell wall components in vaccinesImmune reconstitution inflammatory syndrome in HIV-infected patientsCerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisParadoxical Immune Responses in Non-HIV Cryptococcal MeningitisImmune correlates of HIV-associated cryptococcal meningitisHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.HIV and co-infections.Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.Cryptococcus: from environmental saprophyte to global pathogen.Cryptococcal Disease in HIV-Infected Children.Immune reconstitution inflammatory syndrome associated with pulmonary pathogensImmune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment.Adaptive Immunity to Cryptococcus neoformans Infections.Colliding Epidemics and the Rise of Cryptococcosis.Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report.Transcriptomic Predictors of Paradoxical Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome
P2860
Q26774211-4D6844AE-1C8B-469E-BED8-42902BC0D27FQ28082309-30E4EA2F-F703-4C6D-95A4-E9D4F6672392Q34554521-6B479E30-3681-45CA-9538-3C8E6BB8EE4DQ35085200-4F76D571-676D-4A43-87CB-F0B1036BA028Q35100818-ABA42AAD-2D7A-44B5-B1FD-C7ECE4EFD4DDQ35324835-081FCB99-ED2B-45B5-85A7-EBF8ECC4B1D1Q35645083-3011B968-39CF-4B0A-94AB-1C1A105A580BQ36320051-86BAC555-0CA2-47CE-AA94-B88B19F03805Q36488971-791F13C6-257E-4B38-82DC-82EBBC1C7A84Q36970184-22B32DA1-EC74-4236-BA01-4F7762C69DA9Q37247472-300376FA-8FA1-4E61-8076-8967AA170DD4Q37250158-44D78955-9092-40ED-98C4-32C7C7DBE589Q38904619-4DA5B1E4-CCAD-4A35-A10B-B703A6AA7710Q39065992-918A86AE-AE3B-44CD-BF2F-1825AF0C2BC9Q42209595-28128001-B250-4AD3-BDFA-94571359B54BQ49188733-51D8B0C7-B2FE-47D5-81FB-468FA96B8769Q49287757-9BB2A274-33EB-4334-AE45-1E99596EC26EQ52961767-19D091E4-DCF5-412D-A558-A9AF465C5E4CQ56970361-FEF4D864-727B-41A3-9824-841337003604
P2860
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@en
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@nl
type
label
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@en
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@nl
prefLabel
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@en
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@nl
P2093
P2860
P50
P356
P1476
Cryptococcosis-IRIS is associa ...... cell responses during therapy.
@en
P2093
Andrew Lim
Bernadett I Gosnell
Julian H Elliott
Mohamed-Yunus S Moosa
Saleha Omarjee
Stuart M Levitz
Tim Spelman
William H Carr
P2860
P304
P356
10.1093/INFDIS/JIT271
P407
P577
2013-06-12T00:00:00Z